pharmaceutical investing BioDelivery Sciences Reports Fourth Quarter and Full-Year 2017 Financial Results
pharmaceutical investing BioDelivery Sciences Announces Launch and Availability of BELBUCA® in Canada
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property